Cleared Traditional

K902661 - BARTELS HERPES SIMPLEX VIR FLU MONO ANTIB HSV-1&2 (FDA 510(k) Clearance)

Jul 1990
Decision
43d
Days
Class 2
Risk

K902661 is an FDA 510(k) clearance for the BARTELS HERPES SIMPLEX VIR FLU MONO ANTIB HSV-1&2. This device is classified as a Antisera, Fluorescent, Herpesvirus Hominis 1,2 (Class II - Special Controls, product code GQL).

Submitted by Baxter Healthcare Corp (Bellevue, US). The FDA issued a Cleared decision on July 31, 1990, 43 days after receiving the submission on June 18, 1990.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3305.

Submission Details

510(k) Number K902661 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 1990
Decision Date July 31, 1990
Days to Decision 43 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GQL — Antisera, Fluorescent, Herpesvirus Hominis 1,2
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3305